Retrospective Analysis of Bevacizumab in Combination with Ifosfamide, Carboplatin, and Etoposide in Patients with Second Recurrence of Glioblastoma

Bevacizumab has been reported to be effective for recurrent glioblastoma. In our hospital, ifosfamide, carboplatin, etoposide (ICE) is the second-line chemotherapy for first recurrence of glioblastoma after temozolomide failure. In the present analysis, we retrospectively investigated the feasibilit...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurol Med Chir (Tokyo)
Autors principals: Arakawa, Yoshiki, Mizowaki, Takashi, Murata, Daiki, Fujimoto, Koichi, Kikuchi, Takayuki, Kunieda, Takeharu, Takahashi, Jun C., Takagi, Yasushi, Miyamoto, Susumu
Format: Artigo
Idioma:Inglês
Publicat: The Japan Neurosurgical Society 2013
Matèries:
Special Theme Topic: Treatment of Malignant Brain Tumor
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4508722/
https://ncbi.nlm.nih.gov/pubmed/24140770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2176/nmc.oa2013-0211
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars